Clinical Trial Update: The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study [NA]

View source ↗

Summary

A completed feasibility study evaluating whether heliox delivered through nasal CPAP can prevent early CPAP failure in premature infants with respiratory distre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome Newborn

Drugs mentioned

• Heliox (helium-oxygen mixture)

Snippet

Sponsor: Hawaii Pacific Health | Conditions: Respiratory Distress Syndrome, Newborn | NA | Status: COMPLETED